Vascular Imaging

Which Imaging Study Is Best for Suspected Medium-Vessel Vasculitis (MVV)?

·
Which Imaging Study Is Best for Suspected Medium-Vessel Vasculitis (MVV)?

A 45-year-old male presents to your clinic with a month of fevers, myalgias, significant weight loss, and new-onset, difficult-to-control hypertension. His labs reveal an elevated creatinine and inflammatory markers. You suspect a systemic process, and a medium-vessel vasculitis (MVV) like polyarteritis nodosa is high on the differential. The next step is to confirm the diagnosis and assess the extent of vascular involvement, but which imaging study provides the necessary detail without undue risk? This article details the clinical workflow for the initial imaging workup of suspected MVV. According to the American College of Radiology (ACR) Appropriateness Criteria, for this specific scenario, `Arteriography chest abdomen pelvis` is rated Usually Appropriate.

Who Fits This Clinical Scenario?

This guidance applies to adult and pediatric patients for whom there is a moderate to high clinical suspicion of a medium-vessel vasculitis. The presentation is typically systemic and subacute, involving constitutional symptoms (fever, malaise, weight loss) coupled with signs of organ dysfunction that suggest vascular compromise. Key indicators include new-onset hypertension (suggesting renal artery involvement), abdominal pain (mesenteric ischemia), mononeuritis multiplex, or cutaneous findings like livedo reticularis or tender nodules.

This workflow is specifically for the initial imaging evaluation. It is distinct from other clinical situations that may appear similar but require a different approach:

  • Suspected Large-Vessel Vasculitis (LVV): Patients presenting with symptoms like limb claudication, asymmetric blood pressures, pulselessness, or signs of aortic arch syndrome (e.g., in Takayasu arteritis or giant cell arteritis) fit a different ACR scenario. Their workup focuses on the aorta and its primary branches.
  • Suspected Small-Vessel Vasculitis: Conditions like ANCA-associated vasculitides often present with pulmonary hemorrhage, glomerulonephritis, or palpable purpura. Imaging is less sensitive for direct vessel visualization in these cases, and diagnosis often relies on serology and tissue biopsy.
  • Isolated Organ Manifestation: If a patient presents with symptoms confined to a single organ system (e.g., isolated renal artery stenosis), the workup may begin with a more focused study before escalating to a systemic evaluation.

What Diagnoses Are You Working Up in This Scenario?

The primary goal of imaging in suspected MVV is to identify characteristic vascular abnormalities that support the diagnosis, assess the burden of disease, and rule out mimics. The differential diagnosis is crucial for interpreting the findings.

Polyarteritis Nodosa (PAN) is the classic MVV and a primary target of this workup. Imaging seeks to identify its hallmark features: multiple small aneurysms (microaneurysms) and segmental stenoses in medium-sized visceral arteries, particularly the renal, mesenteric, and hepatic circulations. These findings, often described as a “rosary bead” sign, are highly suggestive of the diagnosis.

Kawasaki Disease, while predominantly a pediatric illness, can have adult-onset forms or present as late sequelae in adulthood. The key finding is coronary artery aneurysms, which can be saccular or fusiform. While coronary evaluation is critical, systemic vessel involvement can also occur, overlapping with the PAN distribution.

Thromboangiitis Obliterans (Buerger’s Disease) is a non-atherosclerotic, segmental inflammatory disease strongly associated with tobacco use. It typically affects the small- and medium-sized arteries and veins of the extremities, but visceral involvement can occur, making it a consideration in the right clinical context.

Non-inflammatory Mimics must also be considered. Fibromuscular Dysplasia (FMD) can cause a “string of beads” appearance, particularly in the renal and carotid arteries, but it lacks the inflammatory wall thickening and aneurysmal changes of vasculitis. Similarly, widespread atherosclerotic disease can cause stenoses and aneurysms, but the patient demographics and distribution of findings often differ from classic MVV.

Why Is Arteriography or CTA the Recommended Approach for This Presentation?

The ACR rates both `Arteriography chest abdomen pelvis` and `CTA chest abdomen pelvis with IV contrast` as Usually Appropriate for the initial imaging of suspected medium-vessel vasculitis. The choice between them often depends on institutional expertise, patient factors, and the specific clinical question.

Catheter-based arteriography is the historical gold standard due to its exceptional spatial resolution. It excels at visualizing the small, distal microaneurysms and subtle luminal irregularities characteristic of diseases like PAN. This level of detail can be crucial for a definitive diagnosis when non-invasive tests are equivocal. However, it is an invasive procedure with risks including vessel dissection, hematoma, and higher, variable radiation exposure (adult RRL=Varies).

CTA with IV contrast has emerged as a powerful and widely used non-invasive alternative. Modern multidetector CT scanners provide high-resolution images that can reliably detect aneurysms, stenoses, and vessel wall thickening across the entire chest, abdomen, and pelvis in a single acquisition. It provides a comprehensive map of vascular involvement and can also reveal parenchymal organ damage (e.g., renal or splenic infarcts). Its primary drawbacks are significant radiation exposure (adult RRL=☢☢☢☢☢ 30-100 mSv) and the need for iodinated contrast.

Alternative modalities are rated lower for this specific initial workup:

  • MRA chest abdomen pelvis with IV contrast is rated May be appropriate. While it avoids ionizing radiation (adult RRL=O 0 mSv), its spatial resolution is generally lower than CTA or arteriography, potentially missing the small microaneurysms that are pathognomonic for PAN. It can be a valuable alternative in younger patients or those with contraindications to iodinated contrast, especially for detecting larger aneurysms or stenoses.
  • US duplex Doppler of various territories is rated Usually not appropriate. Ultrasound is excellent for evaluating specific, accessible vessels (like the carotids or femoral arteries) but is not suitable for the comprehensive, systemic survey required to diagnose or stage a medium-vessel vasculitis. It cannot visualize the mesenteric, renal, or hepatic branch vessels with the necessary scope and detail.

Given its non-invasive nature and excellent diagnostic yield, CTA is often the practical first choice in many centers. Once you’ve decided on CTA, our protocol guide covers the technique, contrast, and reading principles: CT Chest/Abdomen/Pelvis with IV Contrast.

What’s Next After Imaging? Downstream Workflow

The imaging results will guide your subsequent management, which almost always involves collaboration with a rheumatologist. The downstream pathway depends on whether the findings are positive, negative, or indeterminate.

  • If the study is positive for MVV: Findings of multiple aneurysms and stenoses in a characteristic distribution strongly support the diagnosis. The next step is typically to initiate immunosuppressive therapy (e.g., corticosteroids, cyclophosphamide). The imaging also serves as a baseline to monitor treatment response and detect complications like aneurysm rupture or thrombosis. Biopsy of an affected, accessible tissue (e.g., skin, nerve, muscle) may still be pursued for histopathologic confirmation.
  • If the study is negative: A high-quality negative CTA or arteriogram makes a diagnosis of classic, radiographically apparent MVV like PAN less likely, but does not entirely exclude it. If clinical suspicion remains high, the next step may be to pursue a biopsy of a clinically affected organ. The workup should also pivot to more strongly consider small-vessel vasculitides or non-inflammatory mimics.
  • If the study is indeterminate: Ambiguous findings, such as isolated stenoses without clear aneurysms, can be challenging. In this situation, a different modality may add value. For example, if CTA is equivocal, catheter arteriography might be considered for its higher spatial resolution. Alternatively, if inflammatory wall changes are suspected but not definitive on CTA, an MRA may better characterize vessel wall enhancement.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for suspected MVV requires careful attention to detail to avoid common errors. One major pitfall is ordering a non-contrast CT, which is insufficient for evaluating the vessel lumen and wall and will almost certainly need to be repeated with contrast. Another is failing to use a dedicated vascular protocol; proper timing of the contrast bolus is essential for optimal arterial opacification. For pediatric patients, it is critical to use dose-reduction techniques to minimize radiation exposure. Finally, delaying imaging in a patient with acute signs of organ ischemia (e.g., severe abdominal pain) can lead to irreversible damage. If you encounter a critically ill patient with suspected vasculitis, immediate consultation with rheumatology and interventional radiology is warranted to expedite diagnosis and management.

Related ACR Topics and Tools

This article focuses on a single clinical scenario. For a comprehensive overview of imaging for all forms of noncerebral vasculitis, from large-vessel to variable-vessel disease, please consult our parent guide. Additional GigHz tools can help you navigate adjacent scenarios and technical considerations.

Frequently Asked Questions

Why is CTA rated ‘Usually Appropriate’ if conventional arteriography has better spatial resolution?

While catheter arteriography offers the highest spatial resolution, it is an invasive procedure with inherent risks. Modern multidetector CTA provides excellent resolution that is sufficient for diagnosing medium-vessel vasculitis in most cases. It is also non-invasive, faster, and provides valuable information about the vessel wall and surrounding organs, making it a highly effective and often preferred first-line test.

What if my patient has renal insufficiency and cannot receive iodinated contrast for a CTA?

In patients with severe renal dysfunction or a true allergy to iodinated contrast, MRA of the chest, abdomen, and pelvis with gadolinium-based contrast is rated ‘May be appropriate’ and becomes a strong alternative. It avoids both iodine and ionizing radiation. However, be aware of its lower spatial resolution for detecting very small microaneurysms.

Is PET/CT useful for diagnosing medium-vessel vasculitis?

For this specific scenario, FDG-PET/CT is rated ‘Usually not appropriate’. While FDG-PET/CT is a primary imaging tool for large-vessel vasculitis (like Takayasu arteritis) where it can detect inflammation in the aortic wall, its resolution is insufficient to detect inflammation in the smaller arteries affected by classic MVV like polyarteritis nodosa.

The patient is a child. Does that change the recommendation?

The appropriateness ratings are the same for both adults and children. However, the choice between modalities may be different. Due to concerns about lifetime radiation risk, a non-radiation modality like MRA (‘May be appropriate’) is often considered more strongly in pediatric patients, even with its limitations. If CTA is necessary, strict adherence to pediatric-specific low-dose protocols is mandatory.

If imaging is negative but my clinical suspicion for MVV remains high, what is the next step?

A negative high-quality imaging study makes widespread, classic MVV less likely but doesn’t rule it out, especially if the disease is in an early stage or affects vessels below the resolution of the scanner. The next step is typically a biopsy of a clinically involved and accessible tissue, such as skin, a peripheral nerve, or muscle, to look for histopathologic evidence of vasculitis.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026